Story preview
Continue reading on the publisher site for the full article.
Read on publisher →AD HOC NEWS
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Context from Wikipedia on the organisations, people and places in this story.
American pharmaceutical company
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of…
More on Wikipedia ↗Outlets covering it
6
in the last 3 days
First reported
3 days ago
5 outlets since
Countries
5 other outlets reported this story in the last 3 days.
Bristol Myers Squibb stock traded at USD 59.32 on October 6, 2026, while Leerink cut its target to U
Leerink Partners downgraded Bristol-Myers Squibb and cut its price target.Approaching patent cliffs for Eliquis and Opdivo threaten future revenues.U.S. Medicare price negotiations create broader sector policy headwinds.
After Eli Lilly (LLY) secured a new approval for its leukemia drug Jaypirca on Friday, the pharma spotlight turns this week to Roche’s bid to bring immunotherapy into postoperative colon-cancer treatment. Alongside the FDA milestone, Ocular Therapeutix (OCUL) and several gene-therapy developers wil…